This is a StreetInsider.com Premium Only Page

(MGTX) – StreetInsider.com Reports

Feb 13, 2024 08:03 AM MeiraGTx Holdings (MGTX) Announces $50 Million Milestone from Janssen Pharmaceuticals

Dec 21, 2023 08:35 AM MeiraGTx Holdings plc (MGTX) Files $250M Mixed Shelf

Dec 21, 2023 07:02 AM MeiraGTx Holdings plc (MGTX) Reports Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415M

Nov 15, 2023 08:22 AM MeiraGTx Holdings plc (MGTX) PT Lowered to $19 at BofA Securities

Oct 30, 2023 02:31 PM MeiraGTx's (MGTX) Sanofi deal shows 'significant underappreciated value' in portfolio and capabilities - Piper Sandler

Oct 30, 2023 07:31 AM MeiraGTx Holdings (MGTX) Announces 4M Share Offering at $7.50/sh, Pursues Multiple Additional Strategic Opportunities

Oct 9, 2023 08:54 AM Piper Sandler highlights 12 biotech takeover targets as M&A 'about as conducive as we've seen'

Aug 11, 2023 06:09 AM MeiraGTx Holdings plc (MGTX) PT Lowered to $11 at RBC Capital

Aug 3, 2023 05:52 PM MeiraGTx Holdings plc (MGTX) Announces 9.14M Share Offering by Selling Stockholders

Aug 3, 2023 05:51 PM MeiraGTx Holdings plc (MGTX) Announces 3.74M Share Offering by Selling Stockholders

Jul 19, 2023 08:31 AM MeiraGTx Holdings' (MGTX) Gene Therapy Manufacturing Facility in Shannon, Ireland has Received Commercial MIA Authorization for QC Testing

Jun 27, 2023 07:33 AM MeiraGTx (MGTX) Reports Positive Clinical Data from the AQUAx Phase 1 Study of AAV2-hAQP1

May 12, 2023 06:28 AM MeiraGTx Holdings plc (MGTX) PT Lowered to $13 at RBC Capital

May 12, 2023 05:11 AM MeiraGTx Holdings plc (MGTX) PT Lowered to $25 at Piper Sandler

May 3, 2023 08:31 AM MeiraGTx Holdings plc (MGTX) Announces 10.7M Share Private Placement at $5.75/sh

Mar 15, 2023 08:31 AM MeiraGTx Holdings plc (MGTX) PT Lowered to $22 at RBC Capital

Dec 20, 2022 12:01 PM 2023 may be the year of the Smid cap in biotech - Piper Sandler

Dec 15, 2022 09:32 AM MeiraGTx Holdings plc (MGTX) PT Lowered to $22 at BofA Securities

Dec 13, 2022 06:34 PM MeiraGTx Holdings plc (MGTX) PT Raised to $25 at Evercore ISI

Dec 13, 2022 07:30 AM MeiraGTx (MGTX) Announces Positive Clinical Data from the AQUAx Phase 1 Clinical Study of AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia

Nov 10, 2022 08:18 AM MeiraGTx Holdings plc (MGTX) Misses Q3 EPS by 19c

Nov 10, 2022 08:05 AM MeiraGTx Holdings plc (MGTX) Announces $25M Investment from Johnson & Johnson Innovation

Oct 3, 2022 05:53 AM MeiraGTx Holdings plc (MGTX) ReportS Strong Phase 1/2 Data for Botaretigene Sparoparvovec

Jun 28, 2022 04:00 PM MeiraGTx Holdings plc (MGTX) PT Raised to $26 at Evercore ISI

Jun 28, 2022 07:00 AM MeiraGTx Holdings plc (MGTX) Reports Positive Top-Line Data from the MGT009 Phase 1/2 Clinical Study Demonstrating Safety and Improvement in Multiple Domains of Vision

May 13, 2022 05:49 AM MeiraGTx Holdings plc (MGTX) PT Lowered to $18 at Barclays

May 4, 2022 04:03 PM MeiraGTx Holdings plc (MGTX) Reports Clinical Data on Botaretigene Sparoparvovec for the Treatment of X-Linked Retinitis Pigmentosa

Mar 28, 2022 08:37 AM MeiraGTx Holdings plc (MGTX) PT Lowered to $23 at Evercore ISI

Jan 27, 2022 08:32 AM MeiraGTx Holdings plc (MGTX) Receives Clinical Development Milestone Payment from Janssen

Dec 7, 2021 07:01 AM MeiraGTx Holdings plc (MGTX) Reports Positive Prelim AQUAx Phase 1 Data of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia

Sep 9, 2021 08:34 AM MeiraGTx Holdings plc (MGTX) Announces Data at EURETINA 2021 Virtual Meeting Demonstrating Reversal of Disease Progression Following Treatment with AAV5-RPGR in X-Linked Retinitis Pigmentosa

Dec 17, 2020 01:11 PM MeiraGTx Holdings plc (MGTX) PT Raised to 'Street High' $55 at Chardan Capital Markets

Nov 19, 2020 09:26 AM Pre-Open Stock Movers 11/19: (FENT) (APVO) (SONO) Higher; (MGTX) (GPRO) (CUB) Lower (more...)

Nov 19, 2020 07:06 AM MeiraGTx Holdings plc (MGTX) Prices 5M Share Offering at $12.85/Sh

Nov 19, 2020 07:05 AM MeiraGTx (MGTX) Announces Pricing of Public Offering of 5M Ordinary Shares at $12.85/sh

Nov 18, 2020 05:42 PM After-Hours Movers 11/18: (APVO) (CORT) (SONO) Higher; (WRN) (MGTX) (GPRO) Lower (more...)

Nov 18, 2020 04:25 PM MeiraGTx Holdings plc (MGTX) Announces Proposed 5M Share Public Offering of Ordinary Shares

Oct 23, 2020 09:27 AM Pre-Open Stock Movers 10/23: (SAVA) (SLDB) (SAM) Higher; (LLNW) (USX) (INTC) Lower (more...)

Oct 22, 2020 06:08 PM After-Hours Stock Movers 10/22: (SAVE) (CTIC) (SAM) Higher; (CYBE) (USX) (MIST) Lower (more...)

Oct 22, 2020 04:11 PM RBC Capital Starts MeiraGTx Holdings plc (MGTX) at Outperform

Oct 5, 2020 05:58 AM MeiraGTx Holdings plc (MGTX) Reports 9-Mo Data from Phase 1/2 Trial of AAV-RPGR Demonstrating Significant & Sustained Vision Improvement in XLRP

Sep 22, 2020 08:32 AM MeiraGTx (MGTX) Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at EURETINA

Sep 15, 2020 06:05 AM BofA Securities Starts MeiraGTx Holdings plc (MGTX) at Buy

Aug 5, 2020 08:34 AM MeiraGTx Holdings plc (MGTX) Announces Appointment of Robert K. Zeldin, M.D. as Chief Medical

Jul 17, 2020 09:29 AM Pre-Open Movers 07/17: (APDN) (OCN) (HMHC) Higher; (NIO) (NFLX) (ROKU) Lower (more...)

Jul 17, 2020 07:33 AM MeiraGTx Holdings plc (MGTX) Reports Positive Clinical Data from Ongoing Phase 1/2 Clinical Trial (NCT03252847) of AAV-RPGR

Mar 2, 2020 08:32 AM MeiraGTx (MGTX) Announces PPRIME) and ATMP Designations Granted by EMA to AAV-RPGR Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa

Sep 23, 2019 06:31 AM MeiraGTx Holdings plc (MGTX) PT Raised to $45 at Chardan Capital Markets

Sep 10, 2019 08:32 AM MeiraGTx Holdings plc (MGTX) to Present Clinical Data from Phase 1/2 Trial of AAV-RPE65 at Upcoming Scientific Conferences

Sep 3, 2019 08:53 AM UPDATE: Piper Jaffray Starts MeiraGTx Holdings plc (MGTX) at Overweight